Sotac Pharmaceuticals share price
NSE: SOTACPharmaceuticals & Biotechnology
Last close ₹92.00up ₹1.95 (2.17%)
Share price at the NSE close on 21 Oct 2026. Previous close ₹90.05.
52-week range of traded prices to 21 Oct 2026
₹86.00Low, 31 Jul 2026₹139.65High, 28 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹102 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 26 May 2026
- 17.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 26 May 2026
- 1.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.22%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 26 May 2026
- 10.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 26 May 2026
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,200100.0% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 26 May
- Revenue
- ₹60 Cr
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹3.32 Crup 35.77%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 5.5%
Revenue by year
Net profit by year, a loss in red
The years either side of a change of basis do not compare. From the year to Mar 2026, the company's revenue for that year, ₹101 Cr, differs from its half years added, ₹97 Cr.
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025Filed 28 May | Sep 2025Filed 12 Nov | Mar 2026Filed 26 May |
|---|---|---|---|---|---|---|---|---|
| Revenue | 39.7 | 37.7 | 51.6 | 52.2 | 52.6 | 44.4 | 37.0 | 60.1 |
| Net profit | 1.0 | 1.3 | 1.7 | 2.5 | 1.9 | 6.1 | 2.4 | 3.3 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 2.6% | 3.4% | 3.4% | 4.9% | 3.6% | 13.8% | 6.6% | 5.5% |
Consolidated. The 8 half years from Sep 2022, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
The half years either side of a change of basis do not compare. From the half year to Mar 2026, the company's revenue for the year to Mar 2026, ₹101 Cr, differs from its half years added, ₹97 Cr.
Business segments
In the year to Mar 2026 the company reports one business segment, Manufacturing of of a wide range of Pharmaceutical products, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −7.8% | −28.1% | +28.0% | 0.2% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Sotac Pharmaceuticals in market cap. Sotac Pharmaceuticals's own figures are from its last trade, on 21 Oct 2026. 1 company in the table last traded before then: its row is priced on its last trade.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Makers LaboratoriesMAKERSL | 110 | 32.3 | 1.5 | 6.1 | +17.6% | −61.6% | 4.8% | 11.1% | 0.00% |
 Tyche IndustriesTYCHE | 107 | 24.0 | 0.8 | – | −21.0% | −63.5% | 3.2% | −2.5% | 3.36% |
 Alpa LaboratoriesALPA | 104 | – | 0.6 | – | +0.5% | – | – | −1.8% | 0.00% |
 Pharmaids PharmaceuticalsPHARMAID | 102 | – | 2.1 | – | +18.5% | – | −8.5% | −15.8% | 0.00% |
 Veerhealth CareVEERHEALTH | 99 | 64.4 | 4.3 | 23.3 | +177.2% | +199.7% | 6.8% | 11.0% | 0.00% |
 Parmax PharmaPARMAX | 94 | – | – | – | −17.6% | – | – | −70.0% | 0.00% |
 Amwill Health CareAMWILL | 90 | 7.9 | 1.1 | – | +12.1% | +6.4% | 15.2% | – | 1.11% |
 Concord DrugsCONCORD | 90 | 43.7 | – | – | +82.5% | +380.5% | 5.0% | 7.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.Highest ₹0.20 a share, year to Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 23 Sep 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹0.20 |
| 19 Sep 2025 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹0.10 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
8 Oct · Board meeting
Sep 2026
8 Sep · Corporate action
Sotac Pharmaceuticals share price by year
Each calendar year to 2025.Sotac Pharmaceuticals share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 123.10 | +12.6% | 150.00 | 92.35 |
| 2024 | 109.30 | −7.4% | 189.05 | 103.10 |
| 2023 | 118.00 | – | 140.25 | 111.15 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 13 Apr 2023.
Recent sessions
The last 10 trading days to 21 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 21 Oct 2026 | 92.00 | 92.00 | 92.00 | 92.00 | 92.00 | 1,200 | 100.0% |
| 1 Oct 2026 | 90.05 | 90.05 | 90.05 | 90.05 | 90.05 | 1,200 | 100.0% |
| 20 Aug 2026 | 90.05 | 90.05 | 90.05 | 90.05 | 90.05 | 1,200 | – |
| 13 Aug 2026 | 87.40 | 87.40 | 87.40 | 87.40 | 87.40 | 1,200 | – |
| 31 Jul 2026 | 86.00 | 94.90 | 86.00 | 91.95 | 91.93 | 3,600 | – |
| 29 Jul 2026 | 90.40 | 90.40 | 90.40 | 90.40 | 90.40 | 1,200 | – |
| 15 Jul 2026 | 95.10 | 95.10 | 95.10 | 95.10 | 95.10 | 2,400 | – |
| 13 Jul 2026 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 1,200 | – |
| 8 Jul 2026 | 100.50 | 100.50 | 100.50 | 100.50 | 100.50 | 22,800 | – |
| 7 Jul 2026 | 100.00 | 101.00 | 100.00 | 101.00 | 100.02 | 50,400 | – |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Sotac Pharmaceuticals Limited
- NSE symbol
- SOTAC
- ISIN
- INE0O2D01012
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Apr 2023
- Face value
- ₹10